Search Results - Punt, Cornelis J. A.
- Showing 1 - 20 results of 95
- Go to Next Page
-
1
-
2
P-277 A prospective, observational trial to assess the safety and efficacy of regorafenib in patients with metastatic colorectal cancer (mCRC) in routine clinical practice (CORRELA... by Michel, Ducreux, Alfredo, Falcone, Punt, Cornelis J.A., Svetlana, Kobina, Manuel, O'Connor Juan, Andres, Cervantes
Published 2016Text -
3
Real-world cost-effectiveness of cetuximab in the third-line treatment of metastatic colorectal cancer based on patient chart review in the Netherlands by Uyl-de Groot, Carin A., van Rooijen, Elisabeth M., Punt, Cornelis J. A., Pescott, Chris P.
Published 2018Text -
4
-
5
-
6
Plasmacytoid dendritic cells of melanoma patients present exogenous proteins to CD4(+) T cells after FcγRII-mediated uptake by Benitez-Ribas, Daniel, Adema, Gosse J., Winkels, Gregor, Klasen, Ina S., Punt, Cornelis J.A., Figdor, Carl G., de Vries, I. Jolanda M.
Published 2006Text -
7
Statin Use Is Not Associated with Improved Progression Free Survival in Cetuximab Treated KRAS Mutant Metastatic Colorectal Cancer Patients: Results from the CAIRO2 Study by Krens, Lisanne L., Simkens, Lieke H. J., Baas, Jara M., Koomen, Els R., Gelderblom, Hans, Punt, Cornelis J. A., Guchelaar, Henk-Jan
Published 2014Text -
8
Colorectal cancer at high risk of peritoneal metastases: long term outcomes of a pilot study on adjuvant laparoscopic HIPEC and future perspectives by Klaver, Charlotte E.L., Stam, Roos, Sloothaak, Didi A.M., Crezee, Johannes, Bemelman, Willem A., Punt, Cornelis J.A., Tanis, Pieter J.
Published 2017Text -
9
The first steps in the evaluation of a "black-box" decision support tool: a protocol and feasibility study for the evaluation of Watson for Oncology by Keikes, Lotte, Medlock, Stephanie, van de Berg, Daniel J., Zhang, Shuxin, Guicherit, Onno R., Punt, Cornelis J.A., van Oijen, Martijn G.H.
Published 2018Text -
10
Factors Contributing to Cancer-Related Muscle Wasting During First-Line Systemic Treatment for Metastatic Colorectal Cancer by Derksen, Jeroen W G, Kurk, Sophie A, Oskam, Marieke J, Peeters, Petra H M, Punt, Cornelis J A, Koopman, Miriam, May, Anne M
Published 2019Text -
11
Model-based evaluation of the cost effectiveness of 3 versus 6 months’ adjuvant chemotherapy in high-risk stage II colon cancer patients by Jongeneel, Gabrielle, Greuter, Marjolein J. E., van Erning, Felice N., Koopman, Miriam, Vink, Geraldine R., Punt, Cornelis J. A., Coupé, Veerle M. H.
Published 2020Text -
12
Informing metastatic colorectal cancer patients by quantifying multiple scenarios for survival time based on real‐life data by Hamers, Patricia A. H., Elferink, Marloes A. G., Stellato, Rebecca K., Punt, Cornelis J. A., May, Anne M., Koopman, Miriam, Vink, Geraldine R.
Published 2020Text -
13
Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patients by Jongeneel, Gabrielle, Greuter, Marjolein J. E., van Erning, Felice N., Koopman, Miriam, Vink, Geraldine R., Punt, Cornelis J. A., Coupé, Veerle M. H.
Published 2021Text -
14
Advanced analytics and artificial intelligence in gastrointestinal cancer: a systematic review of radiomics predicting response to treatment by Wesdorp, Nina J., Hellingman, Tessa, Jansma, Elise P., van Waesberghe, Jan-Hein T. M., Boellaard, Ronald, Punt, Cornelis J. A., Huiskens, Joost, Kazemier, Geert
Published 2020Text -
15
-
16
-
17
Keeping track of all ongoing colorectal cancer trials using a mobile application: Usability and satisfaction results of the Dutch Colorectal Cancer Group Trials application by Huiskens, Joost, Gałek-Aldridge, Michael S., Bakker, Jean-Michel, Olthof, Pim B., van Gulik, Thomas M., Punt, Cornelis J. A., van Oijen, Martijn G. H.
Published 2018Text -
18
The CAIRO4 study: the role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer – a randomized pha... by ’t Lam - Boer, Jorine, Mol, Linda, Verhoef, Cornelis, de Haan, Anton F J, Yilmaz, Mette, Punt, Cornelis J A, de Wilt, Johannes H W, Koopman, Miriam
Published 2014Text -
19
Clinicopathological factors influencing outcome in metastatic colorectal cancer patients treated with fluoropyrimidine and bevacizumab maintenance treatment vs observation: an indi... by Goey, Kaitlyn K H, Elias, Sjoerd G, Hinke, Axel, van Oijen, Martijn G H, Punt, Cornelis J A, Hegewisch-Becker, Susanna, Arnold, Dirk, Koopman, Miriam
Published 2017Text -
20
Estimating adjuvant treatment effects in Stage II colon cancer: Comparing the synthesis of randomized clinical trial data to real‐world data by Jongeneel, Gabrielle, Klausch, Thomas, van Erning, Felice N., Vink, Geraldine R., Koopman, Miriam, Punt, Cornelis J.A., Greuter, Marjolein J.E., Coupé, Veerle M.H.
Published 2019Text